Analysis of circulating tumor DNA

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

Abstract

Circulating tumor DNA (ctDNA) analysis is currently gaining momentum as an innovative methodology for characterizing the tumor genome and monitoring therapeutic efficacy in the multifocal, genetically and spatially heterogeneous plasma cell malignancy, multiple myeloma (MM). Circulating cell-free DNA (cfDNA), which consists of a combination of DNA derived from both tumor and normal cells, is present in extracellular bodily fluids. The presence of ctDNA within this admixture has been demonstrated recently in MM. In this chapter, we describe the routinely utilized methodology for the extraction and longitudinal analysis of specific mutations present in ctDNA derived from peripheral blood plasma of MM patients.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press
Pages129-145
Number of pages17
ISBN (Electronic)9781493978656
ISBN (Print)9781493978649
DOIs
Publication statusPublished - 1 Jan 2018

Publication series

NameMethods in Molecular Biology
Volume1792
ISSN (Print)1064-3745
ISSN (Electronic)1940-6029

Keywords

  • Cell-free DNA
  • Circulating cell-free nucleic acids
  • Circulating tumor DNA
  • Droplet digital PCR
  • Liquid biopsy
  • Multiple myeloma
  • Peripheral blood plasma

Cite this

Mithraprabhu, S., & Spencer, A. (2018). Analysis of circulating tumor DNA. In Methods in Molecular Biology (pp. 129-145). (Methods in Molecular Biology; Vol. 1792). Humana Press. https://doi.org/10.1007/978-1-4939-7865-6_9
Mithraprabhu, Sridurga ; Spencer, Andrew. / Analysis of circulating tumor DNA. Methods in Molecular Biology. Humana Press, 2018. pp. 129-145 (Methods in Molecular Biology).
@inbook{6604a98ed10f4f11a2b9eec85a37c8ac,
title = "Analysis of circulating tumor DNA",
abstract = "Circulating tumor DNA (ctDNA) analysis is currently gaining momentum as an innovative methodology for characterizing the tumor genome and monitoring therapeutic efficacy in the multifocal, genetically and spatially heterogeneous plasma cell malignancy, multiple myeloma (MM). Circulating cell-free DNA (cfDNA), which consists of a combination of DNA derived from both tumor and normal cells, is present in extracellular bodily fluids. The presence of ctDNA within this admixture has been demonstrated recently in MM. In this chapter, we describe the routinely utilized methodology for the extraction and longitudinal analysis of specific mutations present in ctDNA derived from peripheral blood plasma of MM patients.",
keywords = "Cell-free DNA, Circulating cell-free nucleic acids, Circulating tumor DNA, Droplet digital PCR, Liquid biopsy, Multiple myeloma, Peripheral blood plasma",
author = "Sridurga Mithraprabhu and Andrew Spencer",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-7865-6_9",
language = "English",
isbn = "9781493978649",
series = "Methods in Molecular Biology",
publisher = "Humana Press",
pages = "129--145",
booktitle = "Methods in Molecular Biology",
address = "United States",

}

Mithraprabhu, S & Spencer, A 2018, Analysis of circulating tumor DNA. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1792, Humana Press, pp. 129-145. https://doi.org/10.1007/978-1-4939-7865-6_9

Analysis of circulating tumor DNA. / Mithraprabhu, Sridurga; Spencer, Andrew.

Methods in Molecular Biology. Humana Press, 2018. p. 129-145 (Methods in Molecular Biology; Vol. 1792).

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

TY - CHAP

T1 - Analysis of circulating tumor DNA

AU - Mithraprabhu, Sridurga

AU - Spencer, Andrew

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Circulating tumor DNA (ctDNA) analysis is currently gaining momentum as an innovative methodology for characterizing the tumor genome and monitoring therapeutic efficacy in the multifocal, genetically and spatially heterogeneous plasma cell malignancy, multiple myeloma (MM). Circulating cell-free DNA (cfDNA), which consists of a combination of DNA derived from both tumor and normal cells, is present in extracellular bodily fluids. The presence of ctDNA within this admixture has been demonstrated recently in MM. In this chapter, we describe the routinely utilized methodology for the extraction and longitudinal analysis of specific mutations present in ctDNA derived from peripheral blood plasma of MM patients.

AB - Circulating tumor DNA (ctDNA) analysis is currently gaining momentum as an innovative methodology for characterizing the tumor genome and monitoring therapeutic efficacy in the multifocal, genetically and spatially heterogeneous plasma cell malignancy, multiple myeloma (MM). Circulating cell-free DNA (cfDNA), which consists of a combination of DNA derived from both tumor and normal cells, is present in extracellular bodily fluids. The presence of ctDNA within this admixture has been demonstrated recently in MM. In this chapter, we describe the routinely utilized methodology for the extraction and longitudinal analysis of specific mutations present in ctDNA derived from peripheral blood plasma of MM patients.

KW - Cell-free DNA

KW - Circulating cell-free nucleic acids

KW - Circulating tumor DNA

KW - Droplet digital PCR

KW - Liquid biopsy

KW - Multiple myeloma

KW - Peripheral blood plasma

UR - http://www.scopus.com/inward/record.url?scp=85047793360&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-7865-6_9

DO - 10.1007/978-1-4939-7865-6_9

M3 - Chapter (Book)

SN - 9781493978649

T3 - Methods in Molecular Biology

SP - 129

EP - 145

BT - Methods in Molecular Biology

PB - Humana Press

ER -

Mithraprabhu S, Spencer A. Analysis of circulating tumor DNA. In Methods in Molecular Biology. Humana Press. 2018. p. 129-145. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-7865-6_9